Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

MindMaze

Biotech & Life Sciences · Lausanne, Switzerland · Founded 2012 Unicorn

Digital neuro-therapeutics for brain health and recovery

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$1–10M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value
Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

8 investors on MindMaze's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Hinduja Group
Fondation FIT
Leonardo DiCaprio
Venture Kick
Series B+ 4 investors entered at this stage
EPFL Swiss Federal Polytechnic School of Lausanne
AlbaCore Capital
Salica Investments
Concord Health Partners

Global footprint

Where MindMaze has talent and traffic

AI talent share
1.1% of workforce is AI talent
(1 of 90 staff)
Core AI00%
Other AI11.11%
Non-AI workforce8998.89%
Workforce by country
13 countries with
team presence
🇨🇭 Switzerland55.7%
🇺🇸 United States16.2%
🇮🇳 India9.2%
🇬🇧 United Kingdom3.3%
🇩🇪 Germany3.1%
Top 5 of 13 shown
Web traffic by country
90 monthly visits
across markets
🇮🇳 India111.1%
Top 1 markets shown

Patent intelligence

$4M patent portfolio · 16 active families

Estimated portfolio value
$4M
0.25% of valuation · comparable to top peer BioTelemetry ($5M)
16 active patent families
Where MindMaze innovates Physical medicine and rehabilitationPhysical therapyBiomedical engineeringTransceiverNeuroscience

Where MindMaze concentrates vs peers

Each axis is a top-10 topic across MindMaze and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

MindMaze's 4 investments and acquisitions.

Every disclosed deal where MindMaze appeared as a backer or acquirer, 2017–2018. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across MindMaze's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where MindMaze deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        MindMaze's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about MindMaze

        An AI-synthesized read of the highest-engagement posts about MindMaze on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See MindMaze on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles